X8Z
L-CAPTOPRIL
Created: | 2010-03-14 |
Last modified: | 2011-06-04 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 29 |
Chiral Atom Count | 2 |
Bond Count | 29 |
Aromatic Bond Count | 0 |
Chemical Component Summary | |
---|---|
Name | L-CAPTOPRIL |
Systematic Name (OpenEye OEToolkits) | (2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid |
Formula | C9 H15 N O3 S |
Molecular Weight | 217.285 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(O)C1N(C(=O)C(C)CS)CCC1 |
SMILES | CACTVS | 3.352 | C[CH](CS)C(=O)N1CCC[CH]1C(O)=O |
SMILES | OpenEye OEToolkits | 1.6.1 | CC(CS)C(=O)N1CCCC1C(=O)O |
Canonical SMILES | CACTVS | 3.352 | C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.6.1 | C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1 |
InChIKey | InChI | 1.03 | FAKRSMQSSFJEIM-RQJHMYQMSA-N |
Drug Info: DrugBank
DrugBank ID | DB01197 |
---|---|
Name | Captopril |
Groups | approved |
Description | Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension. |
Synonyms |
|
Brand Names |
|
Indication | For the treatment of essential or renovascular hypertension (usually administered with other drugs, particularly thiazide diuretics). May be used to treat congestive heart failure in combination with other drugs (e.g. cardiac glycosides, diuretics, β-adrenergic blockers). May improve survival in patients with left ventricular dysfunction following myocardial infarction. May be used to treat nephropathy, including diabetic nephropathy. |
Categories |
|
ATC-Code |
|
CAS number | 62571-86-2 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Angiotensin-converting enzyme | MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFA... | unknown | inhibitor |
72 kDa type IV collagenase | MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELA... | unknown | inhibitor |
Matrix metalloproteinase-9 | MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLY... | unknown | inhibitor |
Leukotriene A-4 hydrolase | MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNL... | unknown | inhibitor |
B1 bradykinin receptor | MASSWPPLELQSSNQSQLFPQNATACDNAPEAWDLLHRVLPTFIISICFF... | unknown | |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1560 |
PubChem | 12851888, 44093 |
ChEMBL | CHEMBL1560 |
ChEBI | CHEBI:3380 |
CCDC/CSD | MCPRPL01, MCPRPL02, MCPRPL03 |
COD | 2019870 |